Do four SGLT2 inhibitors lead to different cardiorenal benefits in type 2 diabetes, in chronic heart failure, and in chronic kidney disease?
Saved in:
Published in | European journal of internal medicine Vol. 87; pp. 98 - 99 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
01.05.2021
|
Online Access | Get full text |
Cover
Loading…
Bibliography: | SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1 |
---|---|
ISSN: | 0953-6205 1879-0828 |
DOI: | 10.1016/j.ejim.2021.01.009 |